M7437
/ EMD Serono
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 01, 2026
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=138 | Not yet recruiting | Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
First-in-human • New P1 trial • Solid Tumor
1 to 1
Of
1
Go to page
1